MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,794,863
EPS
-$0.02
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
363,127
491,134
3,813,703.5*
1,517,723
General and administrative
1,445,739
1,668,454
5,361,934.5*
1,130,764
Total operating expenses
1,808,866
2,159,588
9,175,638
2,648,487
Loss from operations
-1,808,866
-2,159,588
-9,175,638*
-2,648,487
Warrant repricing
-
410,154
-
-
Other income, net
14,003
28,672
56,065.5*
39,088
Change in fair value of convertible promissory notes
-
-
576,710.5*
-365,718
Total other income (expense)
14,003
-381,482
-
-
Net loss
-1,794,863
-2,541,070
-8,542,862
-2,975,117
Basic EPS
-0.02
-0.23
-8.842
-2.98
Diluted EPS
-0.02
-0.23
-8.842
-2.98
Basic Average Shares
116,131,213
10,956,650
966,124*
997,038
Diluted Average Shares
116,131,213
10,956,650
966,124*
997,038
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Other income, net
$14,003
(-9.93%↓ Y/Y)
Net loss
-$1,794,863
(65.67%↑ Y/Y)
Total other income
(expense)
$14,003
Loss from operations
-$1,808,866
(59.41%↑ Y/Y)
Total operating
expenses
$1,808,866
(-59.41%↓ Y/Y)
General and
administrative
$1,445,739
(-36.86%↓ Y/Y)
Research and development
$363,127
(-83.24%↓ Y/Y)
Buy us a coffee
Indaptus Therapeutics, Inc. (INDP)
Indaptus Therapeutics, Inc. (INDP)